​

Alto Neuroscience Ownership | Who Owns Alto Neuroscience?


OverviewForecastFinancialsChart

Alto Neuroscience Ownership Summary


Alto Neuroscience is owned by 90.94% institutional investors, 4.12% insiders, and 4.94% retail investors. Commodore capital lp is the largest institutional shareholder, holding 9.44% of ANRO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.17% of its assets in Alto Neuroscience shares.

ANRO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlto Neuroscience90.94%4.12%4.94%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Commodore capital lp2.72M9.44%$61.22M
Alpha wave global, lp3.71M8.66%$94.66M
Vestal point capital, lp2.06M7.15%$46.40M
Perceptive advisors2.01M6.97%$45.18M
Blackrock funding, inc. /de2.73M6.37%$69.60M
Vanguard group1.37M5.04%$24.31M
Vanguard capital management1.69M3.95%$43.16M
Spruce street capital lp1.68M3.92%$42.80M
Vivo capital1.36M3.18%$34.72M
Armistice capital912.00K3.16%$20.50M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
72 investment667.78K30.26%$15.01M
Spruce street capital lp1.68M6.80%$42.80M
Vivo capital1.36M3.82%$34.72M
Commodore capital lp2.72M3.54%$61.22M
Alpha wave global, lp3.71M2.22%$94.66M
Vestal point capital, lp2.06M1.30%$46.40M
Ikarian capital515.00K0.94%$11.58M
Perceptive advisors2.01M0.88%$45.18M
Affinity asset advisors643.34K0.67%$16.42M
Integral health asset management500.00K0.54%$11.24M

Top Buyers

HolderShares% AssetsChange
Commodore capital lp2.72M3.54%900.00K
Marshall wace, llp859.31K0.02%633.81K
Blackrock funding, inc. /de2.73M0.00%605.10K
Vr adviser500.00K0.42%500.00K
Eventide asset management425.00K0.15%425.00K

Top Sellers

HolderShares% AssetsChange
Point72 asset management503.09K0.01%-1.10M
Armistice capital912.00K0.36%-624.00K
Vestal point capital, lp2.06M1.30%-420.93K
Jennison associates---386.43K
Woodline partners lp---359.87K

New Positions

HolderShares% AssetsChangeValue
Vr adviser500.00K0.42%500.00K$11.24M
Eventide asset management425.00K0.15%425.00K$10.85M
Adage capital partners gp385.00K0.01%385.00K$8.65M
Eversept partners, lp125.17K0.15%125.17K$2.81M
Saturn v capital management89.00K0.36%89.00K$2.00M

Sold Out

HolderChange
Federated hermes-110.00
True wealth design-126.00
North star investment management-174.00
Nelson, van denburg & campbell wealth management group-249.00
Physician wealth advisors-377.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202613714.17%38,935,42231.76%901.91%9436.23%25-13.79%
Jun 30, 20261205.26%29,560,33010.17%691.04%6932.69%29-34.09%
Mar 31, 202611311.88%26,804,5408.52%921.12%52-10.34%4372.00%
Dec 31, 202518-76.62%1,951,777-88.35%70.19%10-60.00%4-85.19%
Sep 30, 202517-78.48%1,494,416-91.36%50.14%9-78.57%5-76.19%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.01M3.17%136.10K
Vanguard MStar Total Stk Mkt Idx Invest1.21M3.07%193.40K
Vanguard Morn Total Stk Mkt Idx Investor1.01M2.60%136.10K
iShares Russell 2000 ETF813.87K2.07%-
Franklin Biotechnology Discv A(acc)USD645.53K1.65%-
T. Rowe Price Health Sciences500.85K1.28%500.85K
Vanguard Institutional Extnd Mkt Idx Tr347.15K0.99%624.00
Franklin Biotechnology Discovery A347.90K0.89%-
iShares Russell 2000 Growth ETF299.03K0.76%-1.13K
Fidelity Small Cap Index287.03K0.73%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 16, 2026Hanley Jr. Michael Conick CHIEF OPERATING OFFICERSell$78.39K
Nov 16, 2026Hanley Jr. Michael Conick CHIEF OPERATING OFFICERSell$1.55M
Nov 16, 2026Hanley Jr. Michael Conick CHIEF OPERATING OFFICERSell$309.71K
Nov 18, 2026Hanley Jr. Michael Conick CHIEF OPERATING OFFICERSell$76.69K
Nov 17, 2026Hanley Jr. Michael Conick CHIEF OPERATING OFFICERSell$56.42K

Insider Transactions Trends


DateBuySell
2026 Q4-5
2026 Q3-3
2026 Q2--
2026 Q1--
2025 Q3--

ANRO Ownership FAQ


Who Owns Alto Neuroscience?

Alto Neuroscience shareholders are primarily institutional investors at 90.94%, followed by 4.12% insiders and 4.94% retail investors. The average institutional ownership in Alto Neuroscience's industry, Biotech Stocks , is 181.42%, which Alto Neuroscience falls below.

Who owns the most shares of Alto Neuroscience?

Alto Neuroscience’s largest shareholders are Commodore capital lp (2.72M shares, 9.44%), Alpha wave global, lp (3.71M shares, 8.66%), and Vestal point capital, lp (2.06M shares, 7.15%). Together, they hold 25.25% of Alto Neuroscience’s total shares outstanding.

Does Blackrock own Alto Neuroscience?

BlackRock is not among the top 10 institutional shareholders of Alto Neuroscience.

Who is Alto Neuroscience’s biggest shareholder by percentage of total assets invested?

72 investment is Alto Neuroscience’s biggest shareholder by percentage of total assets invested, with 30.26% of its assets in 667.78K Alto Neuroscience shares, valued at 15.01M$.

Who is the top mutual fund holder of Alto Neuroscience shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Alto Neuroscience shares, with 3.17% of its total shares outstanding invested in 1.01M Alto Neuroscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools